Galen Growth
Galen Growth operates HealthTech Alpha, an AI-native SaaS platform providing decision-grade intelligence on 12,000+ digital health ventures, serving enterprise clients in biopharma, MedTech, insurance, health systems, and institutional investing across APAC, Europe, and North America.
- Company typePrivate
- Founded2016
- HeadquartersBasel, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Galen Growth does
Galen Growth is a privately held digital health intelligence company that builds and commercializes HealthTech Alpha, an AI-native SaaS platform aggregating and validating data on more than 12,000 digital health ventures and 2+ billion data points across funding, partnerships, clinical evidence, and regulatory signals. The platform applies a proprietary Digital Health Taxonomy, ontology framework, and Alpha Score™ metric to deliver point-in-time, governance-friendly intelligence used for benchmarking markets, evaluating ventures, and identifying partnership and M&A opportunities. Around the core platform, the company sells tiered Pro and Enterprise subscriptions, premium research reports and briefings (114+ in a public library), and a higher-margin Advisory service that applies expert judgment for ecosystem strategy, competitive benchmarking, portfolio evaluation, and due diligence.
The company serves enterprise clients across biopharma (GSK, Merck GHI), MedTech (Philips, Medtronic, GE Healthcare), insurance and reinsurance (Swiss Re, Prudential, Munich Re, Mercer Marsh Benefits, FWD, Bupa), health systems, and institutional investors (Munich Re Ventures, B Capital Group). GTM combines enterprise field sales with a product-led self-service model on the platform and channel partnerships for regional distribution — most recently an exclusive India arrangement with All Health Tech announced in December 2025. Pricing is quote-based and not publicly disclosed, reflecting a high-touch enterprise sales motion.
Galen Growth is incorporated in Singapore as Galen Growth Asia Pte. Ltd., with regional headquarters in Basel (Europe, opened 2020) and Boston (North America). The firm reports 1-10 employees, was founded in 2016, and has no disclosed institutional funding beyond a $50,000 seed round in November 2015, indicating a capital-efficient, founder-led operating model.
Galen Growth firmographics
Firmographics- Name
- Galen Growth
- Legal name
- Galen Growth Asia Pte. Ltd.
- Website
- https://galengrowth.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Galen Growth operates HealthTech Alpha, an AI-native SaaS platform providing decision-grade intelligence on 12,000+ digital health ventures, serving enterprise clients in biopharma, MedTech, insurance, health systems, and institutional investing across APAC, Europe, and North America.
- Ownership category
- akta.pro rank
Galen Growth industry classification
Industry- Product category
- Digital Health Intelligence Platform
- NAICS
- Software Publishers (5132), Scientific Research and Development Services (5417)
- SIC
- Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where Galen Growth is headquartered
LocationHeadquarters
- HQ city
- Basel
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Galen Growth business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- HealthTech Alpha SaaS Platform Subscriptions: AI-native SaaS platform providing digital health intelligence with tiered access levels (Pro and Enterprise accounts). Delivers structured intelligence across ventures, markets, funding, partnerships, clinical evidence, and regulatory signals with governance-friendly outputs.
- Advisory Services: Targeted expert support for high-stakes decisions, applying expert judgment on top of platform intelligence. Services include ecosystem strategy, market mapping, competitive benchmarking, portfolio evaluation, partner/M&A target identification, and transaction/investment due diligence.
- Research Reports & Briefings: Reports and briefings powered by HealthTech Alpha data and analytics, covering digital health funding, AI in healthcare, clinical evidence, pharma innovation, health system transformation, and regional ecosystems. Premium reports available to HealthTech Alpha Pro and Enterprise accounts at no additional cost.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | HealthTech Alpha Pro |
| Subscription | Annual | HealthTech Alpha Enterprise |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
Galen Growth product offering
Product offeringCore offering
Galen Growth operates HealthTech Alpha, an AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, providing decision-grade intelligence on funding, partnerships, clinical evidence, and regulatory signals. The company layers Advisory services and Research reports on top of the platform, enabling enterprises to benchmark markets, assess ventures, and make evidence-based strategic, investment, and M&A decisions in digital health.
Product overview
Galen Growth offers a unified platform-plus-services model anchored by HealthTech Alpha, an AI-native SaaS intelligence platform that aggregates and validates digital health venture data across funding, partnerships, clinical evidence, and regulatory signals. Around this core platform, Galen Growth delivers two complementary service layers: Advisory by Galen Growth provides expert strategic support for high-stakes decisions including ecosystem mapping, competitive benchmarking, and M&A due diligence; Research by Galen Growth delivers reports and briefings powered by HealthTech Alpha data. Additional offerings include HealthTech 250 (evidence-led venture rankings) and an Advisory Builder tool for structured inquiry submission. The portfolio serves life sciences companies, payers, institutional investors, and health systems across Asia-Pacific, Europe, and North America.
Differentiator
Problem solved
Functional benefit
Brands
- HealthTech Alpha: The company's flagship AI-driven SaaS platform for digital health intelligence, enabling clients to identify opportunities, benchmark markets, and make evidence-based decisions in Digital Health.
Products and services
- HealthTech Alpha AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, enabling enterprises to benchmark markets, assess ventures, identify partners, and make evidence-based decisions across funding, partnerships, clinical evidence, and regulatory signals.
- Advisory by Galen Growth Expert advisory service powered by HealthTech Alpha, providing targeted strategic support for ecosystem strategy, market mapping, competitive benchmarking, portfolio evaluation, and M&A target identification for high-stakes decisions.
- Research by Galen Growth Reports, briefings, and market analyses built on HealthTech Alpha data, offering insights on digital health funding, AI adoption, clinical evidence, pharma innovation, and ecosystem trends across global markets; available through the Digital Health Research Library of 114+ reports.
- HealthTech 250 Evidence-led ranking and analysis of the top 250 leading digital health ventures, providing intelligence on market leaders and investment targets.
Quantifiable outcome
- 150,000+ digital health leaders engaged through platform and research
- +1 more outcomes
Companies that use Galen Growth
Customer profileNamed customers14 records
Segments7 records
Ideal customer profiles6 records
Galen Growth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature4 records
Galen Growth partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- All Health TechcoreAll Health Tech appointed as exclusive sales partner for HealthTech Alpha in India. The partnership expands access for Indian pharmaceutical companies, insurers, corporates, investors, and government agencies to HealthTech Alpha—the world's most advanced digital health intelligence platform. All Health Tech leads all commercial activities in India, offering localised sales engagement, customer support, and onboarding to power stakeholder AI/LLM environments with digital health intelligence.
- NorstellacorePartnership to expand HealthTech Alpha's ecosystem integrations and data sources, strengthening the platform's data coverage and analytical capabilities for digital health intelligence.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Galen Growth competitors and assessment
Company assessmentDirect peers
- CB Insights: AI-driven market intelligence platform covering venture capital, startups, and corporate strategy, with a dedicated healthcare/digital health practice. Closely comparable to Galen Growth's enterprise intelligence SaaS model and target buyer (corporate strategy, investors).
- DealForma: Healthcare and digital health transaction intelligence platform. Comparable in offering deal, funding, and partnership data to investors and corporate development teams in healthcare.
- PitchBook: Financial data and intelligence platform for venture, private equity, and M&A markets with healthcare coverage. Comparable data SaaS model, subscription tiering, and enterprise buyer overlap (institutional investors and corporate development teams).
- StartUp Health: Digital health insights, reports, and venture rankings; closely comparable thought leadership and digital health venture intelligence offering targeting investors and corporates.
- Norstella: Pharma commercial intelligence platform (parent of Citeline, Evaluate, Pharma Intelligence). Galen Growth's 2023 ecosystem partner; directly comparable in providing decision-grade pharma/digital health intelligence to biopharma.
- Digital Health Intelligence (Informa): Informa-owned digital health research, events, and intelligence service. Comparable in producing digital health reports, briefings, and ecosystem intelligence for healthcare buyers.
- Definitive Healthcare: Healthcare commercial intelligence SaaS covering life sciences, providers, and healthcare IT. Comparable in targeting biopharma and MedTech enterprise buyers with subscription intelligence and analytics workflows.
Broad incumbents
- IQVIA: Global life sciences data, analytics, and technology services giant. Overlaps with Galen Growth in serving biopharma with healthcare market intelligence, though at vastly larger scale and broader scope.
- Bain & Company (Healthcare): Global management consultancy with a major healthcare practice. Overlaps with Galen Growth in digital health strategy and M&A advisory for pharma, payers, and providers, but competes from a consulting-services rather than SaaS perspective.
- LEK Consulting Healthcare: Global strategy consulting with deep healthcare and digital health practice. Comparable in serving biopharma and MedTech on digital health strategy, market expansion, and due diligence, though delivered as advisory rather than a SaaS platform.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Galen Growth social profiles
Digital presenceGalen Growth financial estimates
Financial estimateRevenue estimate
Valuation estimate
Galen Growth leadership team
Management profileNumber of profiles
Profiles1 record
Galen Growth subsidiaries and ownership
Company hierarchySubsidiaries1 record
Galen Growth funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Galen Growth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Galen Growth
What does Galen Growth do?
Galen Growth operates HealthTech Alpha, an AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, providing decision-grade intelligence on funding, partnerships, clinical evidence, and regulatory signals. The company layers Advisory services and Research reports on top of the platform, enabling enterprises to benchmark markets, assess ventures, and make evidence-based strategic, investment, and M&A decisions in digital health.
Is Galen Growth a public or private company?
Galen Growth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Galen Growth founded?
Galen Growth was founded in 2016. It employs 1 to 10 people.
Where is Galen Growth based?
Galen Growth is headquartered in Basel, Switzerland, in the Europe region.
How does Galen Growth make money?
Three revenue lines are on record. HealthTech Alpha SaaS Platform Subscriptions are the primary driver. The others are advisory Services and research Reports & Briefings.
Who are Galen Growth's main competitors?
Direct peers on record are CB Insights, DealForma, PitchBook, StartUp Health, Norstella, Digital Health Intelligence (Informa) and Definitive Healthcare. Broad incumbents are IQVIA, Bain & Company (Healthcare) and LEK Consulting Healthcare.
Does Galen Growth have an API?
No public API is recorded for Galen Growth.
What industry is Galen Growth in?
Galen Growth's product category is Digital Health Intelligence Platform. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132 and its SIC code is 7374.